Skip to main content
Caplight Logo









GLX Analytix

GLX Analytix

Private
CopenhagenHealthcare & Life Scienceshttps://glxanalytix.com/

Last Round

VC Round

Oct 29, 2024

Total Funding Raised

$678,253

Company Overview

GLX Analytix is a biotechnology company that operates a personalized medicine platform utilizing vascular biology and artificial intelligence to advance diagnostics and monitoring for chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

biomarker platformdiagnostic biomarkerprecision medicineblood-based diagnosticsliquid biopsyglycocalyx analysisearly disease detectiontreatment monitoringimmunoassaysAI diagnosticsclinical diagnosticsbiotech researchcompanion diagnosticsdigital biomarkersCDx

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GLX Analytix Comparables

Compare GLX Analytix with similar companies based on industry and business-model similarity.

GLX Analytix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Progentec Diagnostics
78%
Moleculera Biosciences
76%
Octave Bioscience
72%

GLX Analytix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 29, 2024
GrantJul 5, 2024
SeedJun 14, 2022
GrantFeb 1, 2020

Key People

Founding team and executive leadership

Brian DellaValle

Chief Executive Officer Founder

Founding Team

Maital Rasmussen

Fractional Chief Commercial Officer (CCO) Advisory Board

Executive Team

GLX Analytix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 5, 2024

    $598K grant received from Alzheimer's Drug Discovery Foundation.

  • Jun 14, 2022

    Led by DigitalDx Ventures with participation from Labcorp.

GLX Analytix Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GLX Analytix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GLX Analytix's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range15
Year Founded2019
Last FundingOct 29, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?